Jamieson Wellness Inc. (TSE:JWEL) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Jamieson Wellness Inc. (TSE:JWEL) have received a consensus rating of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is C$36.36.

A number of brokerages have commented on JWEL. TD Securities upped their target price on shares of Jamieson Wellness from C$36.00 to C$40.00 in a research note on Friday, August 9th. BMO Capital Markets upped their target price on shares of Jamieson Wellness from C$35.00 to C$42.00 in a research note on Friday, August 9th. Royal Bank of Canada upped their target price on shares of Jamieson Wellness from C$32.00 to C$37.00 in a research note on Friday, August 9th. Finally, Canaccord Genuity Group upped their target price on shares of Jamieson Wellness from C$32.50 to C$36.25 in a research note on Friday, August 9th.

Jamieson Wellness Stock Performance

Shares of TSE:JWEL opened at C$34.46 on Monday. The company has a market capitalization of C$1.43 billion, a price-to-earnings ratio of 40.07 and a beta of 0.61. Jamieson Wellness has a 12 month low of C$22.10 and a 12 month high of C$35.67. The firm’s 50-day moving average is C$32.22 and its 200 day moving average is C$28.98. The company has a current ratio of 3.21, a quick ratio of 1.08 and a debt-to-equity ratio of 92.76.

Insiders Place Their Bets

In other Jamieson Wellness news, Director Michael Al Pilato sold 24,465 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of C$33.41, for a total value of C$817,380.54. In other news, Director Michael Al Pilato sold 24,465 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of C$33.41, for a total value of C$817,380.54. Also, Senior Officer Regan Stewart sold 8,732 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of C$31.65, for a total transaction of C$276,373.04. Over the last quarter, insiders sold 72,058 shares of company stock valued at $2,307,317. Insiders own 0.26% of the company’s stock.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.